Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors Review


Authors: Suarez-Almazor, M. E.; Pundole, X.; Abdel-Wahab, N.; Johnson, D. B.; Gupta, D.; Glezerman, I.; Cooksley, T.; Anderson, R.; Blidner, A.; Choi, J.; Dougan, M.; Ginex, P.; Girotra, M.; Shannon, V. R.; Rapoport, B. L.
Review Title: Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
Abstract: Immune checkpoint inhibitors (ICIs) have emerged as the newest pillar of cancer treatment. Immune-mediated toxicities, stemming from increased activity within the T cell lineage, range from asymptomatic or mild complications to those that are fulminant and potentially fatal. Although they are of variable occurrence, cardiovascular, rheumatic, and renal immune-mediated toxicities are among the most serious of these adverse events. We present MASCC recommendations with respect to the workup and management of cardiovascular, rheumatic, and renal immune-mediated toxicities with a focus on presentations that require treatment with immunomodulating agents. © 2020, Springer-Verlag GmbH Germany, part of Springer Nature.
Keywords: arthralgia; arthritis; cardiomyopathy; myositis; corticosteroids; myocarditis; immunomodulation agents; other immunosuppressive agents; polymyalgia
Journal Title: Supportive Care in Cancer
Volume: 28
Issue: 12
ISSN: 0941-4355
Publisher: Springer Verlag  
Date Published: 2020-12-01
Start Page: 6159
End Page: 6173
Language: English
DOI: 10.1007/s00520-020-05710-8
PUBMED: 32856212
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 December 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Monica Girotra
    22 Girotra
  2. Dipti Gupta
    55 Gupta